Open AccessInterlaboratory Performance in Measurement of Dabigatran and Rivaroxaban
Author(s) -
Oksana Volod,
Marian A. RollinsRaval,
Andrew Goodwin,
Russell A. Higgins,
Thomas Long,
Wayne L. Chandler,
Neil Harris,
Huy P. Pham,
James Isom,
Karen Moser,
John D. Olson,
Kristi Smock,
Amanda M. VanSandt,
Geoffrey D. Wool,
Dong Chen
Publication year - 2021
Publication title -
archives of pathology and laboratory medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.79
H-Index - 117
eISSN - 1543-2165
pISSN - 0003-9985
DOI - 10.5858/arpa.2020-0633-cp
Subject(s) - dabigatran , rivaroxaban , partial thromboplastin time , medicine , direct thrombin inhibitor , thrombin time , prothrombin time , coefficient of variation , pharmacology , warfarin , chromatography , chemistry , atrial fibrillation , coagulation
Assessing direct oral anticoagulant (DOAC) drug levels by reliable laboratory assays is necessary in a number of clinical scenarios.